Learning Objective 1: Describe novel approaches to treating various types of neurodegenerative diseases

Learning Objective 2: Explain the basic concepts of antisense oligonucleotide treatments

Learning Objective 3: Describe the controversies surrounding recent treatment advances for otherwise fatal neuromuscular diseases



Session date: 
06/13/2017 - 8:00am to 9:00am CDT
NorthShore - Evanston
Evanston, IL 60201
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Octavia Kincaid, MD